Boothbay Fund Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.3M | Buy |
522,019
+24,279
| +5% | +$1.32M | 0.7% | 19 |
|
|
2025
Q4 | $23M | Buy |
497,740
+369,009
| +287% | +$16.5M | 0.59% | 32 |
|
|
2025
Q3 | $4.64M | Buy |
128,731
+25,464
| +25% | +$844K | 0.12% | 330 |
|
|
2025
Q2 | $3.36M | Buy |
103,267
+38,109
| +58% | +$1.25M | 0.1% | 386 |
|
|
2025
Q1 | $2.46M | Buy |
+65,158
| New | +$5.21M | 0.08% | 380 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1866 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1893 |
|
|
2023
Q4 | – | Sell |
-27,919
| Closed | -$1.42M | – | 1944 |
|
|
2023
Q3 | $1.42M | Buy |
27,919
+2,575
| +10% | +$127K | 0.05% | 616 |
|
|
2023
Q2 | $1.27M | Sell |
25,344
-15,333
| -38% | -$727K | 0.04% | 735 |
|
|
2023
Q1 | $1.52M | Sell |
40,677
-5,258
| -11% | -$223K | 0.04% | 802 |
|
|
2022
Q4 | $2.2M | Buy |
+45,935
| New | +$1.8M | 0.07% | 565 |
|
|
2022
Q3 | – | Sell |
-22,733
| Closed | -$495K | – | 2563 |
|
|
2022
Q2 | $495K | Sell |
22,733
-7,636
| -25% | -$177K | 0.02% | 1182 |
|
|
2022
Q1 | $733K | Buy |
30,369
+689
| +2% | +$15.1K | 0.02% | 1092 |
|
|
2021
Q4 | $706K | Hold |
29,680
| – | – | 0.02% | 888 |
|
|
2021
Q3 | $753K | Sell |
29,680
-19,441
| -40% | -$471K | 0.03% | 892 |
|
|
2021
Q2 | $1.11M | Sell |
49,121
-5,810
| -11% | -$119K | 0.04% | 643 |
|
|
2021
Q1 | $1.08M | Buy |
54,931
+25,719
| +88% | +$647K | 0.06% | 557 |
|
|
2020
Q4 | $776K | Buy |
+29,212
| New | +$1.09M | 0.04% | 588 |
|
|
2020
Q3 | – | Sell |
-17,637
| Closed | -$558K | – | 1214 |
|
|
2020
Q2 | $558K | Buy |
+17,637
| New | +$567K | 0.05% | 547 |
|
Other funds holding PCVX
RCM
VPM
VCM
PBA
